|
MechanismHMG-CoA reductase inhibitors [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Life Cycle Pharma A/S
0 Patents (Medical) associated with Life Cycle Pharma A/S
100 Deals associated with Life Cycle Pharma A/S
100 Translational Medicine associated with Life Cycle Pharma A/S